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Background 
Momilactones belong to diterpenes group which are typically characterized by a lactone ring linked with 
the pimarane skeleton. According to the first definition of “momilactone” described by Kato and colleagues in 
1973, every lactone structure derived from the rice husk (“籾” - “momi”) can be named as a momilactone. 
Among identified momilactones, momilactones A (MA) and B (MB) are the most common but only detected 
in rice (Oryza sativia) and the moss Hypnum plumaeforme. Previous studies soon manifested the potent 
allelopathic function of MA and MB against plant’s natural enemies such as weeds and blast fungus. Later 
studies confirmed these compounds are authoritative allelochemicals against several pathogens of crops as well. 
Recently, MA and MB were found more implicative with salinity and drought tolerance of rice more than 
allelopathy. They are also exhibited antioxidant, cytotoxic, antitumor and anticancer activities. Though MA and 
MB are promising bioactive constituents in rice, the isolation and purification of the metabolites are complicated 
and laborious. At present, there are very few laboratories in the world that can successfully isolate and purify 
MA and MB. As a result, no commercial MA and MB from chemical companies in Japan or abroad can be 
purchased; thus, knowledge on medicinal and pharmaceutical properties of these compounds has been limited.  
Main objectives 
Therefore, this research was conducted to at first examine medicinal and pharmaceutical properties of pure 
momilactones A and B isolated from rice husks focusing on anti-diabetes, anti-obesity, antioxidant and anti-
skin-aging; and, to determine the potential sources of momilactones A and B by quantifying their contents 
among rice plant parts (bran and endosperm) and among common rice varieties.  
Structure of dissertation 
Chapter 1: Introduction 
Chapter 2: Isolation and purification of momilactones A and B and momilactone-like compounds from rice 
husk 
Chapter 3: Momilactones A and B are α-amylase and α-glucosidase inhibitors  
Chapter 4: Contributions of momilactones A and B to diabetes and obesity inhibitory potentials of rice bran: 
Evidence from in vitro assays  
Chapter 5: Antioxidant and anti-skin-aging properties of momilactones A and B  
Chapter 6: General discussion and conclusion 
Materials and methods 
Materials: Rice husk of Oryza sativa (var. Koshihikari) was collected in Higashi-Hiroshima. Chemicals and 
reagents at high grade were purchased from prestigious providers including Junsei Chemical Co., Ltd., Fujifilm 
Wako Pure Chemical Corporation, Japan, Fisher Scientific company, and Sigma-Aldrich, USA. 
Methods:  
- Pure compounds were isolated and purified by repeated normal phase column chromatography over silica 
gel; 
- Momilactones were identified and confirmed by reliable advance-spectroscopic techniques consisting of 
high-performance liquid chromatography (HPLC), thin-layer chromatography (TLC), gas chromatography-
mass spectrometry (GC-MS), liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS), 
1H and 13C nuclear magnetic resonance (NMR); 
- Biological activities were assayed in vitro by using antioxidant and inhibitory experiments on targeted 
enzymes relevant to diabetes, obesity and skin-aging comprising α-amylase, α-glucosidase, pancreatic α-
amylase, trypsin, elastase, and tyrosinase. 
Main results 
In chapter 2, four bioactive compounds including momilactone E (ME), 7-ketostigmasterol (7KS), 
momilactone A (MA), and momilactone B (MB) were isolated by column chromatography. The inhibitory 
activities of MA, MB, ME, and 7KS were examined on lettuce (Lactuca sativa), barnyard grass (Echinochloa 
crus-galli), and tall goldenrod (Solidago altissima) in bioassays. The allelopathic activities of ME and 7KS were 
compared with those of potent phytoalexin momilactones A (MA) and B (MB), and the standard p-
hydroxybenzoic acid (pHA). Results showed that both MA and MB exhibited stronger inhibitory activity than 
ME and 7KS. MB exerted greater inhibitions than MA but the mixture of MA and MB (1:1, v/v) possessed a 
similar level of inhibition to MB. On the other hand, although ME and 7KS presented non-significant inhibition, 
their mixture of ME-7KS (1:1, v/v) displayed a remarkable inhibition on the growth of S. altissima. Findings of 
this chapter revealed that MA, MB, and the mixture ME-7KS had the potential to control the invasive plant S. 
altissima and the noxious paddy weed E. crus-galli in vitro, but their mode of actions should be further 
investigated. 
In chapter 3, the results of enzymatic in vitro assays showed that both MA and MB exerted potent inhibition 
on α-amylase and α-glucosidase activities. The inhibitory effect of MB on these two key enzymes was greater 
than that of MA. Both MA and MB exerted greater α-glucosidase suppression as compared to that of the 
commercial diabetic inhibitor acarbose. Quantities of MA and MB in rice grain were 2.07 and 1.06 µg/dry 
weight (DW), respectively. This study was the first to confirm the presence of MA and MB in refined rice grain 
and reported the α-amylase and α-glucosidase inhibitory activity of the two compounds. 
Chapter 4 was the first to detect the presence of the two compounds MA and MB in rice bran using the LC-
ESI-MS technique. By in vitro assays, both MA and MB exhibited potent inhibitory activities on pancreatic α-
amylase and α-glucosidase which were significantly higher than γ-oryzanol, a well-known diabetes inhibitor in 
rice bran. Remarkably, MA and MB indicated an effective inhibition on trypsin with the IC50 values of 921.55 
and 884.03 µg/mL, respectively. By HPLC, quantities of MA (6.65 µg/g dry weight) and MB (6.24 µg/g dry 
weight) in rice bran were determined. Findings of this study revealed the α-amylase, α-glucosidase and trypsin 
inhibitors MA and MB contributed an active role to the diabetes and obesity inhibitory potentials of rice bran. 
Chapter 5 reported the potential antioxidant and anti-skin-aging activities of MA and MB. Results from 
antioxidant assays presented a synergistic antioxidant activity of the MA and MB (MAB, 1:1, v/v) by ABTS 
and reducing power assays. Remarkably, in ABTS assay, IC50 value of MAB (0.319 mg/mL) was 4 folds and 9 
folds greater than that of individual MB (1.28 mg/mL) or MA (2.84 mg/mL), respectively. Enzymatic assays 
on pancreatic elastase and tyrosinase indicated that MA and MB were potential cosmeceuticals in protecting 
the skin from wrinkles and freckles. Besides, the validated method for quantification of MA and MB in rice 
grains showed that brown rice grains contained more MA and MB than white rice grains due to the MA and 
MB involvement in bran. Among refined grains, Koshihikari possessed the highest amount of these active 
compounds. The usage of a specific technique in preparation of samples and an advanced UPLC-ESI-MS 
method helped improve the sensitivity of the quantification of MA and MB in various rice grains. 
Conclusion 
This study showed the first-time inhibitory effects of momilactones A (MA) and B (MB) on the key 
enzymes related to human diseases including diabetes, obesity, and skin aging. The results can be applied widely 
in medicine and contribute to the development of the prospective therapeutics. Significantly, for the first time, 
the present research successfully detected and quantified MA and MB in bran and white rice grains. Since most 
of the studies agree with the fact that white rice intake can increase diabetes risk, the existence as diabetic and 
obesity inhibitors of MA and MB in white rice grain may alter the antecedent perspective that white rice 
consumption induced risks of type 2 diabetes and obesity. The HPLC/UPLC-ESI-MS methods and the protocol 
of sample preparation were validated, which helped determine and quantify MA and MB at higher reliability 
and sensitivity. However, further studies should be implemented to assert applicable doses of MA and MB 
before conducting medicinal production, pre-clinical and clinical trials on the two compounds. Finally, given 
that quantities of MA and MB are largely varied among rice cultivars, the breeding of new rice cultivars with 
high amounts of MA and MB may be useful and economical to help control several chronic diseases in human. 
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